DOCSLIB.ORG

A Value 7 ABO Blood Group System 1752, 1781 AB-Type 89 Abzyme

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

Index A value 7 Aclacinomycin 2562, 2563, 2606 ABO blood group system 1752, 1781 Acosamine 902 AB-Type 89 Actinomycetales 2550 Abzyme 380, 393 Activation step 455 Acarbose 87 Active sites 2329, 2353 Acceptor 1391 Acyclic carbohydrates 13, 14 polymer-supported 1397 anti conformations 14 Aceric acid 898 gauche conformation 14 Acetalation 121 nomenclature 14 Acetal–ketal linkage 69 OO interactions 14 Acetals 122 zig-zag conformation 13 acyclic 127 Acyclic spacers 2079 benzylidene 248 Acyl migration, O→S 1802 mixed 1305 Acyl shift, S→N 1804 open-chain 2547 Acylation 129, 1430 Acetal-type protecting group 121 N-Acylation 1431 2-Acetamido-O-acetylated glycals 708 2-O-Acyl-hex-1-enitols 706 p-Acetamidobenzyl 115 Acyloxazolidinone 914 Acetates, anomeric 664 N-Acylpyrroles, α,β-unsaturated 1065 Acetobacter xylinum 78, 1476, 1482 Addition 249, 252, 265 Acetolysis 402 Michael 254 Acetonitrile participation 1327 radical 259 Acetonitrilium ions 580, 581 exo-Addition 316 p-Acetoxybenzyl ether 115 1,2-Addition, lithiated MeSO2Ph 1982 4-Acetoxy-2,2-dimethylbutanoyl 135 1,4-Addition 1061 2-Acetoxy-3,4,6-tri-O-acetyl-D-glucal 702 radical 1040 Acetylation 130 Addition–substitution, radical 329 regioselective 131 Adenosine 1119, 1121 Acetylene-cobalt complex 777 Adenosine triphosphate (ATP) 66 Acetylenosaccharides 2096 Adenosine-diphospho-glucose (ADPGlc) 69 N-Acetylgalactosamine 1798, 2162, 2648 ADEPT 2658 N-Acetylglucosamine 1798 Adhesion domains 2357 in bacterial peptidoglycan 1542 Adjuvants 2668 polymer, in biofilms 1585 ADP-[14C]Glc 1457 N-Acetylglucosaminyltransferases 2256, 2272 ADPGlc 67, 1457 β-N-Acetylhexosaminidases 1396 Adriamycin 2562, 2565 Acetyllactosamine 1750 Advanced glycation end products (AGEs) 415, N-Acetyllactosamine 1370 1740 N-Acetylmannosamine 1861 Affinity labeling 2346 N-Acetyl-D-muramic acid (NAM) 80 AFGP, C-linked 2547 N-Acetylneuraminic acid 20, 24, 534, 596, 724, Agar 1527 772, 787, 2045 Agelagalastatin 562, 643 2-O-Acetyl-3,4,6-tri-O-benzyl-D-glucopyranosyl Agelasphines 756 bromide 708 Aglycon delivery, intramolecular 465, 595, 1303 Achmatowicz reaction 348 Agrobacterium tumefaciens 194 Acid chlorides 1463 AGU 1497 Acid-alcohol modifications 1460 AIDS 1823 Acidic degradations 383 Ajugose 70 Acidulants 854 Alanine 874, 1032 2840 I Index Alaninol 886 Allyl boronates 883 Aldaric acids 190, 1098 Allyl carbonates 138 Aldehydes Allyl ethers 116 alkynylation 1071 Allyl glycoside 159, 620 allylation 883 latent 621, 625 Alditol acetates, methylated 2209, 2211 π-Allyl palladium complex 759 Alditols 194, 202, 2432 Allylation 117, 1036, 1046 Aldohexopyranuronic acid 20 asymmetric 903 Aldol 880 Allylic alkylations 1063 Aldol condensation 867, 891 Allylic stannane 907 SnCl4-promoted intramolecular 1982, 1983 Allylic trichloroacetimidate 389 Aldol cyclization 873 2-(Allyloxy) phenyl acetyl 134 Aldol dimerizations 878 Allyloxycarbonyl group 138 Aldol reactions 871, 882, 894, 2072 2 -(Allyloxycarbonyl)benzyl (ACB) glycosides 639 Aldolase antibodies 872 P-Allylpalladium complex 1990 Aldolases 864, 2161 Allylsamarium species 1990 Aldolization, Zn-proline-catalyzed 880 Allylsilane 771, 777 Aldol-type condensations 308 Allylstannane 781 Aldonic acids 181, 194, 1095 Allyltrimethylsilane 339, 769 Aldonolactones 181, 202, 203, 210, 217, 892 Aloe polysaccharides 1529 Aldopentopyranoses 17 Alternan 75, 1199 Aldoses 843, 876 Alternansucrase 75 Aldosyl phosphates 168 Altohyrtin (spongistatin) 782 Aldosyl phosphites 168 D-Altritol 1093 Aldulosonic acids 2433 Altrosuronic acid 20 Alexine 1895 Alzheimer’s disease 414, 419, 2422 ALG (asparagine-linked glycosylation) 2268 Amadori–Heyns compounds 415 Alginates (algins) 82, 1522 Amicoratopsis trehalostatica 1964 Alkali cellulose 1520 Amide coupling 2083 Alkaline degradations 383 Amide-linked sugars 2080 Alkaloids 2619, 2624 Amido groups 1416 Alkene 682 Amination 1432 isolated 250 reductive 1748, 2123 Alkoxylation 1508 Amino acid, unnatural 1864 Alkoxymethyl ether 128 L-Amino acids, β-deuterated 1034 Alkoxyphosphonium, salt 239 α-Amino aldehyde 888 Alkyl ether 1506 α-Amino nitriles 1038 O-Alkyl glycosyl donor 569 Aminoalditols 880 Alkyl substituents 2142 2-Aminoaldonolactone 893 Alkylation 107, 1013, 1034, 1046, 1051, 1430 p-Aminobenzylether 115 1-O-Alkylation 154 Aminocyclitol antibiotic 2569 Alkyllithium 306, 1050 (1R,2S)-2-Aminocyclopentanecarboxylic acid 874 Alkylmalic acids 1033 6-Amino-6-deoxy starch 1463 Alkyne-cobalt complex 1247 D-/L-2-Amino-2-deoxy-arabinose 893 1-Alkyn-5-ols 725 Aminodeoxycarbohydrates 892 D-Allal 705, 709 4-Amino-4-deoxyfructose 881 Alligator hepatic lectin (AHL) 2457 2-Amino-2-deoxyglyceraldehyde 885 Allomorph 1481, 1482 4-Amino-4-deoxyheptono-1,4-lactam 909 (+)-D-Allonojirimycin 921 2-Amino-2-deoxypyranosyl chlorides 708 Allosamidin 1913, 1915, 1951, 1952 4-Amino-4-deoxy-threo-pentulose 881 Allosamizoline 1952, 1953, 1957, 1963, 1964, 4-Amino-4,5-dideoxy-L-lyxose 916 1972 Aminoglycoside antibiotics 1144, 2569, 2570 D-/L-Allose 876, 878, 879 Aminoglycosides 510, 2126, 2615 Index I 2841 Aminooxy 2164 Anhydrosugars 273, 284, 675, 830, 2384 α-Aminophosphonic acid ester 1039 classification 273 Aminopolyols 924 donors 684 Aminosaccharides 2427 endo-cyclic rings 284 Aminosugars 287, 816, 818, 831, 882, 888, 2574, exo-cyclic rings 284 2605, 2612 reactivity 273 preparation from sugar epoxides 286 1,2-Anhydrosugars 281, 439, 780 3-Amino-2,3,6-trideoxy pyranoses 723 1,3-Anhydrosugars 747 Amphiphatic helix 1774 1,4-Anhydrosugars 748, 784 Amphotericin 1299, 2612 1,6-Anhydrosugars 816, 830 Amygdalin 2548 1,6-Anhydrosugars, C-branched 333 α-Amylases 1195, 1451, 2093, 2331 Anhydrosugars, modified 276 β-Amylases 1452, 2621 2,5-Anhydro-5-thio-D-mannitol 2004 Amylogenin 1742 6,3-Anhydro-6-thio-octanoates 2004 Amylolyases 2340 Animal tests 2146 Amylomaize-5 73, 1441 Ankaraholide A 2558 Amylomaize-7 73, 1441 Annotation 2233 Amylopectin 73, 1426, 1440, 1450 Anomer 377 Amyloplasts 1442 Anomeric O-acylation 160 Amylose 72, 1426, 1440 Anomeric O-alkylation 455 retrograded and dehydrated 1451 Anomeric anion 791, 1356 water-soluble 1441 Anomeric center 153, 154, 180, 202, 213 Anchimeric assistance 463, 2001 Anomeric configurations 2209 Angiogenesis 2579 Anomeric conformation 2202 Angucyclines 2563, 2564 Anomeric O-deacylation 164 Anhydrides, intramolecular 272 Anomeric effect 3, 7, 8, 10, 19 Anhydro amino sugar 751 dipole dipole repulsion 8, 10 1,6-Anhydro bridge 828 exo 9 1,7-Anhydro derivatives 279 kinetic 455, 1301 Anhydro linkage 272 thermodynamic 455 Anhydro sugars, anomeric 738 Anomeric ester 525 Anhydroalditols 213, 214 Anomeric leaving group 664 1,5-Anhydro-2-deoxy-D-arabino- Anomeric oxygen 455 hex-1-enitol 700 Anomeric radicals 785, 2049, 2055 Anhydroerythritol 1101, 1121 Anomeric sulfones 2034 1,6-Anhydrofuranoses 279, 738 Anomerization 408, 430 synthesis 279 in situ 767 3,6-Anhydrofuranoses 293 Antagonist 1226 D-Anhydroglucopyranose 1476 Antarctic fish 1773 1,6-Anhydro-β-D-glucopyranose 274 Antennae 1749, 1750, 2461 1,3-Anhydroglucopyranoses 284 Anthocyanidin glycosides 2548 1,6-Anhydro-β-D-glucose 1111 Anthocyanins 2548, 2593 2,6-Anhydroheptitols 925–927 Anthracyclines 2562, 2604 1,6-Anhydrohexofuranoses 748 Anti-adhesive 2367 1,6-Anhydro-ε-D-hexopyranoses 21 Antibacterial 2430 1,6-Anhydro-D-ido-pyranose 275 Antibiotics 510, 1831, 2008, 2600 1,6-Anhydromuropeptide 742 activity 1763 2,3-Anhydro-nucleoside 289 resistances 2550 1,6-Anhydropyranoses 21, 738, 783 Antibodies 1815, 2145, 2386, 2666 boat conformation 21 Anticancer vaccines 1810 chair conformations 21 Anti-epileptic 2426 Anhydrosucrose 297 Antifreeze glycoproteins (AFGPs) 1773, 2547 derivatives 297 Antigen, F1α 551, 1821 2842 I Index Antigen presentation 2661 Ascorbic acid 186, 199, 211, 852, 985, 2631 Antigenic determinants 1752, 1755 Asialoglycoprotein receptor 1787, 2455 Antigens 2661, 2719 Aspartame 846 tumor-associated 1782, 2655 Aspergillus niger 1452 tumor-specific 2154 Asterosaponins 2559 O-Antigens 85 Asx-Turn 1778 biosynthesis 1566 Asymmetric synthesis 1029, 1031 structural diversity 1562 Atropisomerism 1763, 2575 Anti-β-hydroxy-α-aminoacids 880 Aureolic acids 2559, 2608 Anti-inflammatory drugs 1789, 1843 Australine 1895 Antimycobacterial 2407 Automated synthesis 1233 Antioxidative activity 2596 Auxiliary 1321, 1324 Antiperiplanar lone pair hypothesis (ALPH) 586 Avermectins 534, 2550, 2552, 2610 Antisense 1861 Avian virus H5N1 1947 Antithrombotic 2407 Avidity 2449 Antitumor activity 2604 Avilamycin 2554 Antiviral 996, 2407 Axes of symmetry, two-fold 2464 APC 2660 Axial attack 771 L-Apiose 837, 889 Axial bonds 64 Apoptosis 2663 Aza-Achmatowicz reaction 945 Aprosulate 2094 Aza-Cope/Mannich tandem reactions 391 APTS 1880 Aza-C-disaccharides 1154 L-Arabinal 701 1-Azafagomine 915, 916 Arabinans 1489 Azafuranose 1892 D-Arabinaric acid 1100 Azasugars 299, 366, 401, 751, 906, 1888 D-Arabinitol 87, 898 naked 930 Arabinofuranose 1575 septanose-type 299 β-Arabinofuranosylation 559 Azidation 251 stereoselective 636 p-Azido benzyl 115 Arabinogalactans 78, 498, 1425, 1530, 1536, 1572, Azido group 1339 1621, 2288 Azidoaldehydes 869 biosynthesis 1576 4-Azido-3-chlorobenzyl (ClAzb) 1256 drug target 1581 6-Azidoketones 868 larch 1530 Azidonitration 199, 253 Arabinoglucuronoxylan 1490 Azidophenyl selenylation 200, 260 D-Arabinonic acid 1098 Azidosphingosine glycosylation procedure 482 D-Arabinose 985 3 -Azidothymidine (AZT) 295, 2015 L-Arabinose 1489 Aziridine ring opening 1938 Arabinose-binding protein, bacterial 2459 meso-Aziridines Arabinosyltransferase catalytic desymmetrization (CDMA) 1950 inhibitors 1581 catalytic enantioselective
Recommended publications
  • Postulated Physiological Roles of the Seven-Carbon Sugars, Mannoheptulose, and Perseitol in Avocado

    Postulated Physiological Roles of the Seven-Carbon Sugars, Mannoheptulose, and Perseitol in Avocado

    J. AMER. SOC. HORT. SCI. 127(1):108–114. 2002. Postulated Physiological Roles of the Seven-carbon Sugars, Mannoheptulose, and Perseitol in Avocado Xuan Liu,1 James Sievert, Mary Lu Arpaia, and Monica A. Madore2 Department of Botany and Plant Sciences, University of California, Riverside, CA 92521 ADDITIONAL INDEX WORDS. ‘Hass’ avocado on ‘Duke 7’ rootstock, phloem transport, ripening, Lauraceae ABSTRACT. Avocado (Persea americana Mill.) tissues contain high levels of the seven-carbon (C7) ketosugar mannoheptulose and its polyol form, perseitol. Radiolabeling of intact leaves of ‘Hass’ avocado on ‘Duke 7’ rootstock indicated that both perseitol and mannoheptulose are not only primary products of photosynthetic CO2 fixation but are also exported in the phloem. In cell-free extracts from mature source leaves, formation of the C7 backbone occurred by condensation of a three-carbon metabolite (dihydroxyacetone-P) with a four-carbon metabolite (erythrose-4-P) to form sedoheptulose-1,7- bis-P, followed by isomerization to a phosphorylated D-mannoheptulose derivative. A transketolase reaction was also observed which converted five-carbon metabolites (ribose-5-P and xylulose-5-P) to form the C7 metabolite, sedoheptu- lose-7-P, but this compound was not metabolized further to mannoheptulose. This suggests that C7 sugars are formed from the Calvin Cycle, not oxidative pentose phosphate pathway, reactions in avocado leaves. In avocado fruit, C7 sugars were present in substantial quantities and the normal ripening processes (fruit softening, ethylene production, and climacteric respiration rise), which occurs several days after the fruit is picked, did not occur until levels of C7 sugars dropped below an apparent threshold concentration of ≈20 mg·g–1 fresh weight.
  • Biological Values of Cultivated Mushrooms – a Review

    Biological Values of Cultivated Mushrooms – a Review

    Acta Alimentaria, Vol. 48 (2), pp. 229–240 (2019) DOI: 10.1556/066.2019.48.2.11 BIOLOGICAL VALUES OF CULTIVATED MUSHROOMS – A REVIEW J. VETTER* Department of Botany, University of Veterinary Sciences, H-1077 Budapest, Rottenbiller u. 50. Hungary (Received: 3 July 2018; accepted: 11 October 2018) Cultivated mushrooms are not only valuable foods of our age (functional foods) but contain certain benefi cial chemical components (high level of K and P, very low content of Na, considerable quantities of some microelements, high and valuable protein but low fat contents). Some cultivated mushrooms have anti-carcinogenic effects caused fi rst of all by polysaccharides (Lentinan: Lentinula edodes) and by triterpenoids (ganoderic acids: Ganoderma lucidum or unsaturated fatty acids: linoleic, linolenic acids); antidiabetic effects, which can improve the sugar metabolism of patients (Coprinus comatus, Ganoderma lucidum, Agaricus bisporus); anti-microbial effects, caused partly by smaller triterpenoids or by higher molecules, i.e. by direct or indirect effects: via stimulation of the immune system. Certain mushrooms have antioxidant effects, provided mostly by higher radical scavenging activity of phenolic (fl avonoid) components. The chemical composition and its biological effects form together the biological values of the cultivated mushrooms. The following review would like to summarize the most important facts of this topic. Keywords: cultivated mushrooms, chemical components, nutritional values, anti-carcinogenic, antidiabetic, antimicrobial, antioxidant effects Mushrooms have been consumed since earliest historical times; Greeks believed that mushrooms provided strength for warriors, the Romans named them as the “Food of the Gods”. In countries of the Orient, certain mushrooms were believed “elixir of life” etc.
  • Shiitake Mushroom: a Tool of Medicine

    Shiitake Mushroom: a Tool of Medicine

    REVIEW ARTICLE Shiitake Mushroom: A Tool of Medicine Taufiqur Rahman1, MBK Choudhury2 1National Mushroom Development Project, Savar, Dhaka 2Directorate General of Health Services, Dhaka ABSTRACT Medicinal mushrooms have an established history of use in traditional oriental therapies. Contemporary research has validated and documented much of the ancient knowledge. Over the last three decades, the interdisciplinary fields of science that study medicinal mushrooms has sprung up and has increasingly demonstrated the potent and unique properties of compounds extracted from a range of species. Currently, the field is being developed into a very fruitful area. Modern clinical practice in Japan, China, Korea and other Asian countries rely on mushroom-derived preparations. Mushrooms have been studied for nutritional and medical purposes for its various potential anti-tumoral and immunomodulatory componests like polysaccharides that have been identified. For medical purposes, mushrooms have been consumed to prevent cancer and cardiac diseases, to improve blood circulation and to reduce blood cholesterol level. Some of these mushrooms have also been used for the treatment of physical and emotional stress, osteoporosis, gastric ulcers and chronic hepatitis, for the improvement of the quality of life of patients with diabetes and especially for the stimulation of immunity. Shiitake has a history of medicinal uses. The mushroom is used as anticarcinogenic, anti- inflammatory, antioxidant, antifungal, antibacterial, antiviral as well as antithrombotic in cardiovascular disorders. This article has been written to throw some light on Shiitake mushroom which has many nutritional values. Many Shiitake preparations came in market containing the active ingredients which can replace many other marketed synthetic medicines and may prove to have promising results with fewer side effects.
  • United States Patent 1191 Lll] 3,983,266 Bahls [451 Sept

    United States Patent 1191 Lll] 3,983,266 Bahls [451 Sept

    United States Patent 1191 lll] 3,983,266 Bahls [451 Sept. 28, 1976 [54] METHOD FOR APPLYING METALLIC 3.776.740 [2/1973 Sivcrz ct al. .......................... .. l06/l SILVER TO A SUBSTRATE OTHER PUBLICATIONS [75] Inventor: Harry Bahls, Wayne, Pa. lvanov et al., Chem. Abs. 43:2548c, I949, [73] Assignee: Peacock Laboratories, Inc., Philadelphia, Pa. Primary Examiner-Ralph S. Kendall [22] Filed: Oct. 9, I974 I 57] ABSTRACT [2!] ,Appl. No.: 513,417 High efficiency deposition of silver on the surface of a substrate is obtained by providing a solution contain [52] [1.8. CI ............................... .. 427/164; 427/165; ing reducible dissolved silver in the presence of an al 427/168; 427/424; 427/426; l06/l kali metal hydroxide and ammonia, all of which are [51] Int. CLZ. ......................................... .. C23C 3/02 applied to the substrate in the presence of an aqueous [58] Field of Search .............. .. l06/l; 427/l68. I69, solution of a moderating reducer containing :1 poly 427/165, I64, 426, 304, 125, 425 hydric alcohol of the formula CH2OH(CHOH),,C H,OH, where n is an integer from 1 to 6. Preferably [56] References Cited the polyhydric alcohol is sorbitol, and in a preferred UNITED STATES PATENTS embodiment a moderator is the form of a thio glycerol is present. 2,996,406 8/l96l Weinrich ........... ............ .. 427/168 3,772,078 ll/l973 Polichcttc ct al ................. .. l06/l X l5 Claims, No Drawings 3,983,266 1 Other objects and advantages of this invention, in METHOD FOR APPLYING METALLIC SILVER TO cluding the economy of the same, and the case with A SUBSTRATE which it may be applied to existing silver coating equip ment and apparatus, will further become apparent BRIEF SUMMARY OF THE INVENTION 5 hereinafter.
  • Effect of Intake of Food Hydrocolloids of Bacterial Origin on the Glycemic Response in Humans: Systematic Review and Narrative Synthesis

    Effect of Intake of Food Hydrocolloids of Bacterial Origin on the Glycemic Response in Humans: Systematic Review and Narrative Synthesis

    nutrients Review Effect of Intake of Food Hydrocolloids of Bacterial Origin on the Glycemic Response in Humans: Systematic Review and Narrative Synthesis Norah A. Alshammari 1,2, Moira A. Taylor 3, Rebecca Stevenson 4 , Ourania Gouseti 5, Jaber Alyami 6 , Syahrizal Muttakin 7,8, Serafim Bakalis 5, Alison Lovegrove 9, Guruprasad P. Aithal 2 and Luca Marciani 2,* 1 Department of Clinical Nutrition, College of Applied Medical Sciences, Imam Abdulrahman Bin Faisal University, Dammam 31441, Saudi Arabia; [email protected] 2 Translational Medical Sciences and National Institute for Health Research (NIHR) Nottingham Biomedical Research Centre, Nottingham University Hospitals NHS Trust and University of Nottingham, Nottingham NG7 2UH, UK; [email protected] 3 Division of Physiology, Pharmacology and Neuroscience, School of Life Sciences, Queen’s Medical Centre, National Institute for Health Research (NIHR) Nottingham Biomedical Research Centre, Nottingham NG7 2UH, UK; [email protected] 4 Precision Imaging Beacon, University of Nottingham, Nottingham NG7 2UH, UK; [email protected] 5 Department of Food Science, University of Copenhagen, DK-1958 Copenhagen, Denmark; [email protected] (O.G.); [email protected] (S.B.) 6 Department of Diagnostic Radiology, Faculty of Applied Medical Science, King Abdulaziz University (KAU), Jeddah 21589, Saudi Arabia; [email protected] 7 Indonesian Agency for Agricultural Research and Development, Jakarta 12540, Indonesia; Citation: Alshammari, N.A.; [email protected] Taylor, M.A.; Stevenson, R.; 8 School of Chemical Engineering, University of Birmingham, Birmingham B15 2TT, UK Gouseti, O.; Alyami, J.; Muttakin, S.; 9 Rothamsted Research, Harpenden, Hertfordshire AL5 2JQ, UK; [email protected] Bakalis, S.; Lovegrove, A.; Aithal, G.P.; * Correspondence: [email protected]; Tel.: +44-115-823-1248 Marciani, L.
  • Traditional Medicine

    Traditional Medicine

    MINISTRY OF HEALTH DEPARTMENT OF MEDICAL RESEARCH (LOWER MYANMAR) -4 rf,"d .1, l,.ifr M '\t $.,iJ+j AI{I{OTATED BIBLIOGRAPHY OF TRADITIOI{AL MEDTCII\E RESEARCH CARRTED OUT AT DMR (LM) nURIf{G 196s-2011 f# #a# €€# 6rdffi t u 6 l6'6 ktibilicetidiT \ &, ft Ministry of Health Department of Medical Research (Lower Myanmar) Central Biomedical Library ANNOTATED BIBLIOGRAPHY OF TRADITIONAL MEDICINE RESEARCH CARRIED OUT AT DMR (LM) DURING 1965-2011 Compiled by Cho Mar Oo BA (Economics); DipLibSc Librarian, Central Biomedical Library Staff of Central Biomedical Library May Aye Than MBBS, MMedSc (Pharmacology) Deputy Director & Head Pharmacology Research Division Staff of Pharmacology Research Division Aung Myo Min BSc (Physics); DipLibSc; RL Librarian & Head (Retd.) Central Biomedical Library Ye Htut MBBS, MSc (Medical Parasitology) (London) DLSHTM, FRCP (Edin) Deputy Director-General Myo Khin MBBS, MD (New South Wales), DCH, FRCP (Edin) Acting Director General PREFACE Throughout recorded history, people of various cultures have relied on traditional medicine. Worldwide, only an estimated ten to thirty percent of human health care is delivered by conventional, biomedically oriented practitioners. The remaining seventy to ninety percent ranges from self-care according to folk principles, to care given in an organized health care system based on traditional medicine. Likewise, in Myanmar health care system, the existence of traditional medicine along with allopathic medicines is well recognized. Myanmar traditional medicine dates back 2,000 years and is well accepted and widely used by the people throughout history. Burma Medical Research Institute since it was established in 1963 had started a program of research on traditional medicinal plants including laboratory screening tests on animal models of herbs with reputed pharmacological properties-such as anti-dysentery, bronchodilator, hypoglycemic effects.
  • In Chemistry, Glycosides Are Certain Molecules in Which a Sugar Part Is

    In Chemistry, Glycosides Are Certain Molecules in Which a Sugar Part Is

    GLYCOSIDES Glycosides may be defined as the organic compounds from plants or animal sources, which on enzymatic or acid hydrolysis give one or more sugar moieties along with non- sugar moiety. Glycosides play numerous important roles in living organisms. Many plants store important chemicals in the form of inactive glycosides; if these chemicals are needed, the glycosides are brought in contact with water and an enzyme, and the sugar part is broken off, making the chemical available for use. Many such plant glycosides are used as medications. In animals (including humans), poisons are often bound to sugar molecules in order to remove them from the body. Formally, a glycoside is any molecule in which a sugar group is bonded through its carbon atom to another group via an O-glycosidic bond or an S-glycosidic bond; glycosides involving the latter are also called thioglycosides. The sugar group is then known as the glycone and the non-sugar group as the aglycone or genin part of the glycoside. The glycone can consist of a single sugar group (monosaccharide) or several sugar groups (oligosaccharide). Classification Classification based on linkages Based on the linkage of sugar moiety to aglycone part 1. O-Glycoside:-Here the sugar is combined with alcoholic or phenolic hydroxyl function of aglycone.eg:-digitalis. 2. N-glycosides:-Here nitrogen of amino group is condensed with a sugar ,eg- Nucleoside 3. S-glycoside:-Here sugar is combined with sulphur of aglycone,eg- isothiocyanate glycosides. 4. C-glycosides:-By condensation of a sugar with a cabon atom, eg-Cascaroside, aloin. Glycosides can be classified by the glycone, by the type of glycosidic bond, and by the aglycone.
  • Prebiotics: a Novel Approach to Treat Hepatocellular Carcinoma

    Prebiotics: a Novel Approach to Treat Hepatocellular Carcinoma

    Hindawi Canadian Journal of Gastroenterology and Hepatology Volume 2017, Article ID 6238106, 11 pages https://doi.org/10.1155/2017/6238106 Review Article Prebiotics: A Novel Approach to Treat Hepatocellular Carcinoma Naz Fatima,1 Tasleem Akhtar,1 and Nadeem Sheikh1,2 1 Cell and Molecular Biology Lab, Department of Zoology, University of the Punjab, Q-A Campus, Lahore 54590, Pakistan 2Cell and Applied Molecular Biology (CAMB), University of the Punjab, Q-A Campus, Lahore 54590, Pakistan Correspondence should be addressed to Nadeem Sheikh; [email protected] Received 13 February 2017; Accepted 19 April 2017; Published 10 May 2017 Academic Editor: JoseL.Mauriz´ Copyright © 2017 Naz Fatima et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Hepatocellular carcinoma is one of the fatal malignancies and is considered as the third leading cause of death. Mutations, genetic modifications, dietary aflatoxins, or impairments in the regulation of oncogenic pathways may bring about liver cancer.An effective barrier against hepatotoxins is offered by gut-liver axis as a change in gut permeability and expanded translocation of lipopolysaccharides triggers the activation of Toll-like receptors which stimulate the process of hepatocarcinogenesis. Prebiotics, nondigestible oligosaccharides, have a pivotal role to play when it comes to inducing an antitumor effect. A healthy gut flora balance is imperative to downregulation of inflammatory cytokines and reducing lipopolysaccharides induced endotoxemia, thus inducing the antitumor effect. 1. Introduction pathway are deregulated as well, but on a marginal scale.
  • Inhibitory Effect and Enzymolysis Kinetics of Lentinan on Α-Glucosidase

    Inhibitory Effect and Enzymolysis Kinetics of Lentinan on Α-Glucosidase

    Topics in Chemical & Material (TCME) 1(1) (2018 Engineering ) 312-314 Contents List available at VOLKSON PRESS New Materials and Intelligent Manufacturing (NMIM) DOIJournal : http://doi.org/10.26480/icnmim.01.2018. Homepage: https://topicsonchemeng.org.my/ 312.314 ISBN: 978-1-948012-12-6 INHIBITORY EFFECT AND ENZYMOLYSIS KINETICS OF LENTINAN ON Α-GLUCOSIDASE Meifu Wu, Hongli Zhou* School of Chemistry and Pharmaceutical Engineering, Jilin Institute of Chemical Technology, Jilin 132022, China. *Corresponding Author Email: [email protected] This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. ARTICLE DETAILS ABSTRACT Article History: Objective: To study the inhibitory activity and enzymolysis kinetics of lentinan on α-glucosidase. Methods: The enzyme-agent screening model was used to investigate the optimal conditions of α-glucosidase action. In vitro Received 26 June 2018 enzyme kinetics was studied by changing the substrate concentration, reaction time, pH conditions and Accepted 2 July 2018 temperature. Results: The optimal reaction conditions of α-glucosidase were reaction time 120min, reaction Available online 1 August 2018 temperature 50°C, buffer pH 6.0, concentration of substrate PNPG 0.1089 mol/L. Conclusion: 1g/L concentration of lentinan has good inhibitory activity against α-glucosidase, and the inhibitory effect of lentinan is competitive inhibition. KEYWORDS Lentinan, α-glucosidase, enzymolysis kinetics. 1. INTRODUCTION 3. EXPERIMENTAL METHODS Edible fungi are widely used in folk, and their active substances can promote the secretion of insulin and related hormones, so that the 3.1 Determination of enzyme inhibitory activity and function of liver, pancreas and other organs of diabetic patients can return calculation of inhibition rate of enzyme activity to normal [1].
  • Autohydrolysis of Lentinus Edodes for Obtaining Extracts with Antiradical Properties

    Autohydrolysis of Lentinus Edodes for Obtaining Extracts with Antiradical Properties

    foods Article Autohydrolysis of Lentinus edodes for Obtaining Extracts with Antiradical Properties Liceth Rocío Huamán-Leandro 1 , María Jesús González-Muñoz 1,2 , Catalina Fernández-de-Ana 3, Arturo Rodríguez-Blanco 3, María Dolores Torres 1,2,* and Herminia Domínguez 1,2 1 Departamento de Enxeñería Química, Universidade de Vigo (Campus Ourense), Edificio Politécnico, As Lagoas, 32004 Ourense, Spain; [email protected] (L.R.H.-L.); [email protected] (M.J.G.-M.); [email protected] (H.D.) 2 CITI-Universidade de Vigo, Tecnopole, San Cibrao das Viñas, 32901 Ourense, Spain 3 Hifas da Terra SL, Portamuiños,7, 36154 Bora Pontevedra, Spain; [email protected] (C.F.-d.-A.); [email protected] (A.R.-B.) * Correspondence: [email protected]; Tel.: +34-988-387-075 Received: 7 November 2019; Accepted: 3 January 2020; Published: 9 January 2020 Abstract: The autohydrolysis of Lentinus edodes was proposed for the extraction of components with antioxidant properties. Operation under non-isothermal conditions was evaluated and compared with isothermal heating. The influence of process severity was assessed in the range of 0.18 to 4.89 (temperature between 50 and 250 ◦C), up to 80% (d.b.) The influence of process severity during the autohydrolysis of Lentinus edodes was assessed in the range 0.3 to 4.89 (temperature between 50 and − 250 ◦C). Up to 80% (d.b.) of the initial raw material could be solubilized at 210 ◦C. The different behavior of the saccharide and phenolic fractions was observed with the treatment temperature. Whereas the highest concentration of the saccharide components (mainly glucooligosaccharides) was found at 210 ◦C, the maximum phenolic yield was identified at 250 ◦C.
  • SYNTHESIS and FUNCTIONALITY STUDY of NOVEL BIOMIMETIC N-GLYCAN POLYMERS KA KEUNG CHAN Bachelor of Science Appalachian State Univ

    SYNTHESIS and FUNCTIONALITY STUDY of NOVEL BIOMIMETIC N-GLYCAN POLYMERS KA KEUNG CHAN Bachelor of Science Appalachian State Univ

    SYNTHESIS AND FUNCTIONALITY STUDY OF NOVEL BIOMIMETIC N-GLYCAN POLYMERS KA KEUNG CHAN Bachelor of Science Appalachian State University May 2014 submitted in partial fulfillment of requirements for the degree of DOCTOR OF PHILOSOPHY IN CLINICAL AND BIOANALYTICAL CHEMISTRY at the CLEVELAND STATE UNIVERSITY May 2021 We hereby approve this dissertation for KA KEUNG CHAN Candidate for the Doctor of Philosophy in Clinical and Bioanalytical Chemistry degree for the Department of Chemistry and Cleveland State University’s College of Graduate Studies by ______________________________________________________ Xue-Long Sun, Ph.D., Dissertation Committee Chairperson Chemistry, 4/22/2021 Department & Date ____________________________________________________________ Aimin Zhou, Ph.D., Dissertation Committee Member Chemistry, 4/22/2021 Department & Date ____________________________________________________________ Bin Su, Ph.D., Dissertation Committee Member Chemistry, 4/22/2021 Department & Date ____________________________________________________________ David Anderson, Ph.D., Dissertation Committee Member Chemistry, 4/22/2021 Department & Date ____________________________________________________________ Moo-Yeal Lee, Ph.D., Dissertation Committee Member Chemical & Biomedical Engineering, 4/22/2021 Department & Date ____________________________________________________________ Aaron Severson, Ph.D., Dissertation Committee Member Biological, Geological and Environmental Sciences, 4/22/2021 Department & Date Date of Defense: 22 APRIL 2021 DEDICATION I dedicate the entirety of this degree to my family. My mother, Mrs. Yu Hung Cheung, to whom I owe the world and I unreservedly dedicate the entire of my life and achievements – thank you for everything that you have done for me. My fiancée, Ms. Mengni Xu, to whom I dedicate the rest of my life with my undying love – you deserve all of my achievements as much as I do. ACKNOWLEDGEMENT I extend my most sincere gratitude to Dr.
  • Reports of the Scientific Committee for Food

    Reports of the Scientific Committee for Food

    Commission of the European Communities food - science and techniques Reports of the Scientific Committee for Food (Sixteenth series) Commission of the European Communities food - science and techniques Reports of the Scientific Committee for Food (Sixteenth series) Directorate-General Internal Market and Industrial Affairs 1985 EUR 10210 EN Published by the COMMISSION OF THE EUROPEAN COMMUNITIES Directorate-General Information Market and Innovation Bâtiment Jean Monnet LUXEMBOURG LEGAL NOTICE Neither the Commission of the European Communities nor any person acting on behalf of the Commission is responsible for the use which might be made of the following information This publication is also available in the following languages : DA ISBN 92-825-5770-7 DE ISBN 92-825-5771-5 GR ISBN 92-825-5772-3 FR ISBN 92-825-5774-X IT ISBN 92-825-5775-8 NL ISBN 92-825-5776-6 Cataloguing data can be found at the end of this publication Luxembourg, Office for Official Publications of the European Communities, 1985 ISBN 92-825-5773-1 Catalogue number: © ECSC-EEC-EAEC, Brussels · Luxembourg, 1985 Printed in Luxembourg CONTENTS Page Reports of the Scientific Committee for Food concerning - Sweeteners (Opinion expressed 14 September 1984) III Composition of the Scientific Committee for Food P.S. Elias A.G. Hildebrandt (vice-chairman) F. Hill A. Hubbard A. Lafontaine Mne B.H. MacGibbon A. Mariani-Costantini K.J. Netter E. Poulsen (chairman) J. Rey V. Silano (vice-chairman) Mne A. Trichopoulou R. Truhaut G.J. Van Esch R. Wemig IV REPORT OF THE SCIENTIFIC COMMITTEE FOR FOOD ON SWEETENERS (Opinion expressed 14 September 1984) TERMS OF REFERENCE To review the safety in use of certain sweeteners.